Jesse Kreger

13PUBLICATIONS
28CO-AUTHORS
Tumour immunologyMolecular targetsMolecular evolutionEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 11, 2026
Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

|Apr 03, 2026
A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells.

Aaron G Baugh, Yingtong Liu, Edgar Gonzalez

|Aug 20, 2025
Beyond RECIST: mathematical modeling and Bayesian inference reveal the importance of immune parameters in metastatic breast cancer.

Jesse Kreger, Edgar Gonzalez, Xiaojun Wu

|Jul 15, 2025
Cancer systems immunology reveals myeloid-T cell interactions and B cell activation mediate response to checkpoint inhibition in metastatic breast cancer.

Edgar Gonzalez, Jesse Kreger, Yingtong Liu

|Jun 30, 2025
Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with entinostat + nivolumab + ipilimumab.

Evanthia Roussos Torres, Ludmila Danilova, Jospeh Tandurella

|Nov 26, 2024
Developmental hematopoietic stem cell variation explains clonal hematopoiesis later in life.

Jesse Kreger, Jazlyn A Mooney, Darryl Shibata

Pageof 3

Frequent Collaborators

9 joint publications

Adam MacLean

7 joint publications

Evanthia T Roussos Torres

5 joint publications

Aaron G Baugh

2 joint publications

Natalia L Komarova